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Abstract
The mesopontine tegmentum, including the pedunculopontine and laterodorsal tegmental nuclei 
(PPN and LDT), provides major cholinergic inputs to midbrain and regulates locomotion and 
reward. To delineate the underlying projection-specific circuit mechanisms we employed 
optogenetics to control mesopontine cholinergic neurons at somata and at divergent projections 
within distinct midbrain areas. Bidirectional manipulation of PPN cholinergic cell bodies exerted 
opposing effects on locomotor behavior and reinforcement learning. These motor and reward 
effects were separable via limiting photostimulation to PPN cholinergic terminals in the ventral 
substantia nigra pars compacta (vSNc) or to the ventral tegmental area (VTA), respectively. LDT 
cholinergic neurons also form connections with vSNc and VTA neurons, however although photo-
excitation of LDT cholinergic terminals in the VTA caused positive reinforcement, LDT-to-vSNc 
modulation did not alter locomotion or reward. Therefore, the selective targeting of projection-
specific mesopontine cholinergic pathways may offer increased benefit in treating movement and 
addiction disorders.
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Introduction
The pedunculopontine nucleus (PPN) is a heterogeneous brainstem structure that contains 
cholinergic (ChAT), glutamatergic, and GABAergic neurons (Benarroch, 2013; Jenkinson et 
al., 2009). Accumulating evidence suggests that PPN ChAT neurons play key roles in both 
motor and non-motor behaviors (Morita et al., 2014). Parkinson’s disease patients with gait 
disorders and postural instability display degeneration of the PPN ChAT neurons, and the 
severity of balance deficits is correlated with a reduction in PPN ChAT-neuron numbers and 
activity (Bohnen et al., 2013; Bohnen et al., 2009). In parkinsonian non-human primate 
models, chemical lesion of PPN ChAT neurons is necessary and sufficient to impair gait and 
balance (Karachi et al., 2010). In addition to affecting motor behavior, ChAT-neuron-
selective chemical lesions of the PPN also affect drug-seeking behavior (Lanca et al., 2000). 
These studies suggest that PPN ChAT neurons are instrumental for normal function in 
movement and reward reinforcement; however, they do not identify the downstream 
effectors.
The PPN projects to multiple targets in the basal ganglia, midbrain, cerebellum, thalamus, 
and the reticular formation (Ballanger et al., 2009; Benarroch, 2013; Dautan et al., 2014; 
Jenkinson et al., 2009; Marani et al., 2008). Although electrically and pharmacologically 
stimulating PPN neurons in vivo leads to overall excitatory outcomes in downstream nuclei 
(Ballanger et al., 2009; Blaha et al., 1996), the projections from the PPN to individual 
downstream neurons are complex. Two notable targets of PPN ChAT circuitry, the substantia 
nigra pars compacta (SNc) and the ventral tegmental area (VTA), are implicated in 
locomotion and reward processing (Bermudez and Schultz, 2014; Bromberg-Martin et al., 
2010; Ikemoto, 2007; Lerner et al., 2015; Roeper, 2013). ChAT, glutamatergic, and 
GABAergic neurons of the PPN form convergent connections onto SNc and VTA neurons, 
but their synaptic contacts with individual neurons are often non-overlapping (Futami et al., 
1995; Good and Lupica, 2009; Scarnati et al., 1986). The multifaceted roles of SNc and 
VTA neurons in exploratory activity, habituation, reinforcement, aversion (Bromberg-Martin 
et al., 2010; Friedman et al., 2014; Lerner et al., 2015; Roeper, 2013; Walsh et al., 2014), 
and the involvement of multiple nuclei in locomotion and reward (Benarroch, 2013; 
Bromberg-Martin et al., 2010; Ikemoto, 2007; Jenkinson et al., 2009; Kravitz and Kreitzer, 
2012) adds experimental complexity to the assessment of how PPN ChAT tone in the VTA 
and SNc patterns goal-directed behaviors. Whether selectively and temporarily enhancing 
the tonic activity of PPN ChAT neurons, without affecting PPN glutamatergic and 
GABAergic neurons, is sufficient to recruit SNc and VTA neurons and to regulate the 
aforementioned behaviors is unknown. A strategy that enables specific modulation of ChAT 
projections without perturbing glutamatergic and GABAergic projections can facilitate both 
in vitro and in vivo characterization of ChAT circuitry originated in the PPN.
To dissect out the behavioral effect of ChAT signaling along each PPN-to-midbrain circuit, 
we have employed optogenetic tools (Gradinaru et al., 2009; Gradinaru et al., 2010; Hausser, 
2014; Walsh et al., 2014) and ChAT-Cre rats (Witten et al., 2011). Electrical and chemical 
interventions, which are commonly used to study the anatomy and physiology of the PPN, 
do not offer the spatiotemporal or cell-type specificity required to selectively harness 
specific PPN ChAT projections to the VTA and SNc, or to examine differences in PPN cell 
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connectivity with SNc and VTA nuclei. Highlighting the requirement for precise spatial 
targeting of neuronal manipulations, it is noteworthy that the dorsal and ventral tiers of the 
SNc (dSNc and vSNc) project to distinct sub-regions of the striatum and may have 
differential vulnerability to neurodegenerative assaults (Hassan and Benarroch, 2015). Thus 
they merit investigation as separate subnuclei.
We found that optogenetic modulation of PPN ChAT somata altered both motor activity and 
reward reinforcement, whereas targeted photo-stimulation of PPN ChAT terminals in the 
vSNc or VTA granted separable control of these physiological processes. Importantly, these 
results do not rule out cholinergic control of midbrain functions from non-PPN sources. 
Indeed, as shown before (Chen and Lodge, 2013; Lodge and Grace, 2006; Mena-Segovia et 
al., 2008) and confirmed here, ChAT neurons in the laterodorsal tegmental nucleus (LDT), 
also formed functional connections with midbrain neurons. While photo-excitation of these 
connections in the VTA regulated reward reinforcement, photoexcitation of LDT ChAT 
terminals in the vSNc did not alter locomotion, which contrasts with the effects of PPN 
originating cholinergic modulation. Therefore, ChAT projections from the PPN and the LDT 
to the vSNc and VTA play distinct roles in regulating motor and reward behaviors, and could 
be refined therapeutic targets for movement disorder and drug addiction.
Results
Previous studies (Benarroch, 2013; Jenkinson et al., 2009; Mena-Segovia et al., 2008; 
Oakman et al., 1995) have demonstrated connections between PPN neurons and SNc/VTA 
neurons by neuronal tracing and electrophysiological techniques. As these techniques often 
lacked cell specificity, ChAT connections were neither imaged in intact form nor were they 
selectively stimulated without also perturbing glutamatergic and GABAergic connections. 
We injected adeno-associated virus serotype 5 (AAV5) carrying Cre-dependent (DIO; 
double-floxed inverse open reading frame) ChR2-eYFP into the PPN of ChAT-Cre rats to 
selectively label ChAT neurons and their projections (Fig. 1A). To visualize the projections 
to the SNc and VTA, we used PACT clearing (Treweek et al., 2015; Yang et al., 2014) for 
facile and accurate mapping of dense, long-range fibers in 1 – 2 mm thick brain sections. We 
observed ChR2-eYFP labeled axonal fibers from PPN ChAT neurons within both the dorsal 
and ventral tiers of the SNc (dSNc and vSNc) as well as within the VTA (Fig. 1B, C).
We confirmed the functional properties of these connections by performing whole-cell 
patch-clamp recordings from SNc and VTA neurons adjacent to ChR2-expressing PPN 
ChAT axonal fibers in live midbrain slices of ChR2-injected rats (Fig. 1D). ChAT neurons 
usually form connections with downstream neurons through non-synaptic volume 
transmission (Miwa et al., 2011). Since ACh released in response to a short stimulation 
epoch is rapidly hydrolyzed by acetylcholinesterase before reaching its receptors, long 
stimulation epochs are necessary in order for ACh to accumulate and subsequently activate 
ACh receptors. Therefore, to increase our probability of detecting existing functional ChAT 
transmission, we applied 5 – 10 s continuous blue light stimulation (Fig. 1E–G). Under these 
conditions, we detected inward currents in 33%, 24%, and 44% of vSNc, dSNc, and VTA 
neurons, respectively (Fig. 1E–I). Meanwhile, blue light accelerated neuronal firing (Fig. 
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1E–G, J). These data suggest that PPN ChAT neurons form excitatory connections with SNc 
and VTA neurons.
Midbrain neurons contain both nicotinic and muscarinic ACh receptors (nAChRs and 
mAChRs) (Drenan and Lester, 2012; Miwa et al., 2011; Yeomans, 1995), and either is 
capable of mediating the response to light-induced ChAT release. We observed 
photocurrents that were not significantly changed by atropine, a mAChR antagonist, but that 
were significantly blocked by mecamylamine (MEC), a nAChR antagonist (Fig. 1K; Fig. 
S1A, D); furthermore, MEC also blocked the enhancement of firing in response to photo-
excitation (Fig. 1E). These data suggest that nAChRs predominantly mediate the 
connectivity between PPN ChAT neurons and SNc/VTA neurons.
Given that nAChRs modulate neurotransmitter release in midbrain (Dani and Bertrand, 
2007), the nAChRs that mediate the photocurrents could be located on the recorded neurons 
or on afferent terminals releasing other neurotransmitters, such as, glutamate or GABA. To 
define where these nAChRs are located, we further characterized the pharmacological 
properties of the photocurrents. We observed that bicuculline (10 μM, Bic), a GABAA 
receptor blocker, did not affect the photocurrents in midbrain neurons, but 10 μM MEC 
blocked these currents (Fig. 1K; Fig. S1B, E). In some midbrain neurons (8/18), the 
photocurrents were completely blocked by glutamate receptor antagonists (APV and 
CNQX); whereas, in other neurons (10/18), the combined application of APV and CNQX 
only partially reduced the currents, and MEC blocked the remaining currents (Fig. 1K; Fig. 
S1C, F). These results suggest that nAChRs both in afferent glutamatergic terminals and in 
midbrain neurons are important targets of endogenously released ACh from PPN.
The above optogenetic tracing data (Fig. 1B, C) support the hypothesis that the SNc and 
VTA are downstream targets of PPN ChAT neurons. Since the SNc and VTA are involved in 
locomotion and reward reinforcement (Bromberg-Martin et al., 2010; Lerner et al., 2015; 
Maskos, 2008; Patterson et al., 2015; Roeper, 2013), it follows that PPN ChAT activity may 
impact locomotion and reward reinforcement. To test this hypothesis, we selectively and 
reversibly manipulated opsin-expressing PPN ChAT neurons in freely behaving rats.
Similar to previous studies (Jenkinson et al., 2009), our data illustrate that ChAT neurons 
reside throughout the PPN and account for almost half of all neurons in both the rostral and 
caudal PPN (Fig. 2A, B; Fig. S2A). To tailor practical optogenetic stimulation paradigm (i.e. 
duration and frequency) to modulate neurons within their spiking capability, we therefore 
characterized the biophysical properties of PPN ChAT neurons using brain-slice patch-
clamp recordings (Fig. 2C–H). Most PPN neurons fired spontaneously at <10 Hz (Fig. S2B). 
When increasing steps of depolarizing current were injected into PPN neurons, the firing 
rates of ChAT neurons increased more than non-ChAT neurons (Fig. 2E, Tab S1), consistent 
with our data showing that ChAT neurons had higher input resistance (Fig. 2F). The optimal 
stimulation duration to evoke reliable single action potential for PPN neurons was 10 ms 
(Fig. 2G, H; Fig. S2C, D; Tab S2). Thus, we applied 10 ms light pulses to evoke action 
potentials in the following ex vivo and in vivo experiments involving optogenetic excitation.
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To achieve optogenetic control of PPN ChAT neurons we stereotaxically delivered AAV5-
DIO- ChR2-eYFP or Arch3.0-eYFP genes into the PPN of ChAT-Cre rats (Chow et al., 
2010; Mattis et al., 2012; Witten et al., 2011) (Fig. 3A–C, I–K; Fig. 4A). Whole-cell patch-
clamp recordings in PPN brain slices (Fig. S3A, D) confirmed functional expression levels 
of virally transduced ChR2 and Arch3 in PPN neurons: blue and green light stimulation 
evoked robust photocurrents in recorded cells (Fig. 3D, L; Fig. S3C, E, F) and effectively 
modified the firing patterns (Fig. 3E, L). Opsin expression was specific to ChAT neurons 
(Fig. 3C, K). Additionally, blue light pulses (10 ms) reliably evoked inward currents (Fig. 
S3E) and action potentials (Fig. 3E–H) in PPN ChAT neurons expressing ChR2 (Fig. S3A).
To understand the behavioral contributions of PPN ChAT neurons, we monitored freely 
moving rats for changes in locomotor activity in response to photo-modulation of opsin-
expressing PPN ChAT neurons. For photo-excitation, we applied 20 Hz stimuli (Fig. 4A; 
Fig. S4A) because: 20 Hz is higher than the average spontaneous firing rates (<12 Hz) of 
PPN neurons shown in our in vitro data (Fig. S2B; Tab S1) and in previous in vivo studies 
(Norton et al., 2011), and 20 Hz is within the frequency range (20–25Hz) used for electrical 
stimulation of the PPN and prior photo-excitation (at 20Hz) of PPN ChAT neurons that 
effectively enhances movement (Benarroch, 2013; Jenkinson et al., 2009; Plaha and Gill, 
2005; Roseberry et al., 2016; Stefani et al., 2007). To quantify locomotor behavior, we used 
an open field test (see Methods). Exposure to ChR2-activating blue light (20 Hz, 10 ms 
pulse width) robustly and reversibly increased locomotion (Fig. 4B, Fig. S4D). Moreover, 
the enhancement of locomotion during photo-excitation was abolished by MEC (2 mg/kg, 
i.p.) (Fig. S4G–I). These data indicate that increased PPN ChAT activity is sufficient to 
promote locomotion by enhanced activation of nAChRs. To test whether spontaneous firing 
in PPN ChAT neurons is necessary to maintain normal locomotion, we photo-inhibited 
Arch3-expressing PPN ChAT neurons with continuous green light during open field tests. 
Photo-inhibition significantly reduced locomotor activity, and this effect reversed upon light 
termination (Fig. 4C, Fig. S4J). Neither blue nor green light stimulation altered locomotion 
in control mCherry rats (Fig. 4B, C; Fig. S4B, D, J), eliminating the possibility that virus 
transduction or light stimulation exerted non-specific actions on locomotion. During testing, 
ChR2, Arch3 and corresponding mCherry cohorts exhibited similar levels of baseline 
activity (Fig. S4E, K). These data provide a causal link between the activity of PPN ChAT 
neurons and locomotion.
The PPN contains neurons that respond to either movement or reward signals, as shown by 
prior in vivo single-unit recordings (Lau et al., 2015; Norton et al., 2011; Okada and 
Kobayashi, 2013). Given that ChAT neurons are a dominant neuronal population in the PPN 
(Fig. 2B), and that PPN neuronal activity has been linked to numerous physiological 
functions, our optogenetic modulation of ChAT-neuron activity could affect non-motor 
behaviors as well. To confirm the hypothesized role of PPN ChAT signaling in reward 
processing, we used a conditioned place preference (CPP) paradigm (Fig. 4D, see 
supplementary materials) to test whether photo-excitation and photo-inhibition of PPN 
ChAT neurons during place conditioning would induce place preference and aversion, 
respectively (Fig. 4E). On the first day, the rats preferred the dark compartment (350 – 550 
s) to the white compartment (50 – 250 s) (Fig. S5A). Therefore, we applied a biased light-
conditioning paradigm on the following four consecutive days. Since lesioning PPN ChAT 
Xiao et al. Page 5
Neuron. Author manuscript; available in PMC 2017 April 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
neurons reduces nicotine self-administration (Lanca et al., 2000), we hypothesized that 
exciting and inhibiting PPN ChAT neurons would cause positive and negative reinforcement, 
respectively. In a CPP paradigm, the time spent in the light-paired side should increase in 
response to PPN ChAT photo-excitation but decrease with PPN ChAT photo-inhibition. To 
avoid ceiling and floor effects for conditioning, we paired ChR2 rats with blue light pulses 
in the non-preferred (white) compartment and Arch3 rats with green light in preferred (dark) 
compartment (Fig. 4E). As controls, we paired mCherry rats with blue light pulses in the 
white compartment and with green light in the dark compartment (Fig. 4E). After light-
conditioning, ChR2 rats exhibited a statistically significant increase in the time spent in the 
compartment paired with photo-excitation (Fig. 4F, G), whereas Arch3 rats displayed a 
significant reduction in the time spent in the compartment paired with photo-inhibition (Fig. 
4H, I). Therefore, modulation of PPN ChAT somata is also sufficient to bidirectionally affect 
reward processing. Note that four days of light-conditioning had only minor effects on 
locomotion in the post-conditioning session (Fig. S5B, C).
Based on our findings that optogenetic modulation of PPN ChAT neurons modifies both 
motor and reward behaviors, we reasoned that the downstream targets of ChAT projections 
may be involved in conveying these behaviors. To understand the role of PPN projections to 
the SNc and VTA in controlling locomotion and reward in vivo, we restricted optogenetic 
modulation to ChAT axon terminals in the vSNc (Fig. 5A, B, Fig. S6A–C) and VTA (Fig. 
6A, B; Fig. S7A–C). We chose to target vSNc-projecting and not dSNc-projecting fibers as 
the smaller size of the vSNc and its anatomical segregation from the VTA and dSNc (Fig. 
1B; Fig. 5A, B) facilitate its optogenetic isolation and recruitment.
In the open field test, photo-excitation of PPN-to-vSNc projections increased locomotion 
(Fig. 5C, D; Fig. S6D). Photo-excitation of terminals could potentially cause back-
propagating action potentials (Jennings et al., 2013) in the vSNc projecting PPN ChAT 
neurons and recruit downstream nuclei other than the vSNc, with the PPN-to-vSNc 
connection playing only a minor role. To ensure that the vSNc was indeed a key contributor, 
we photo-inhibited the projections of PPN ChAT neurons to the vSNc in rats injected with 
AAV5-DIO-Arch3.0-eYFP in the PPN (Fig. 5A; Fig. S6C) and observed reduced 
locomotion (Fig. 5E, F; Fig. S6E), confirming the critical role of this connection in motor 
control. Photo-excitation of the PPN-to-vSNc projections had no effect on CPP (Fig. 5G, H).
In contrast to PPN-to-vSNc projections, photo-excitation of PPN-to-VTA projections did not 
change locomotion in the open field test (Fig. 6C, D; Fig. S7A, B), but did attenuate place 
aversion to the previously non-preferred compartment (Fig. 6E, F) in CPP. This effect could 
be related to increased activity of VTA neurons (Fig. S7F–H), because direct stimulation of 
VTA neurons is sufficient to cause reward reinforcement (Tsai et al., 2009). We next tested 
whether photo-inhibition of PPN-to-VTA projections has opposite effects compared with 
photo-excitation of the projections. Since Arch3.0 can have limitations for long epoch 
terminal inhibition (Mahn et al., 2016), we virally transduced eNpHR3.0-eYFP into PPN 
ChAT neurons and utilized green-light to inhibit the terminals of these neurons (Fig. 6A; 
Fig. S7C–E). Conditioning eNpHR3.0-injected rats with photo-inhibition of PPN-to-VTA 
projections reduced time spent in the light-paired compartment (Fig. 6G, H).
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Collectively, the above data indicate that targeted optogenetic modulation of PPN ChAT 
terminals located in the vSNc and VTA bidirectionally affected locomotion and reward 
reinforcement, respectively. In addition to the PPN, midbrain neurons also receive 
cholinergic signaling from the LDT (Hassan and Benarroch, 2015; Maskos, 2008; Mena-
Segovia et al., 2008). Previous studies reveal that LDT ChAT neurons project preferentially 
to the VTA and sparsely to the SNc (Hassan and Benarroch, 2015; Mena-Segovia et al., 
2008). However, it is still an open question whether the ChAT projections from the LDT to 
the midbrain have similar functions to those from the PPN. To answer this question, we 
performed photo-excitation of LDT ChAT terminals in both the VTA and vSNc. We 
delivered AAV5-DIO-ChR2-eYFP to the LDT of ChAT-Cre rats; 66% (368/556) of ChAT 
neurons contained ChR2 (Fig. 7A, B). In brain slices, photo-excitation of ChR2-eYFP 
expressing LDT ChAT somata evoked inward currents and action potentials (Fig. 7C); when 
applied to LDT ChAT terminals, blue light evoked inward currents in 22, 18, and 33% of 
vSNc, dSNc and VTA neurons, respectively (Fig. 7D, E, F). These proportions were similar 
to those of midbrain neurons responding to PPN ChAT terminal stimulation (Fig. 1H, Fig. 
7F). We observed that APV+CNQX partially blocked the photocurrents in 5/10 neurons, but 
did not change the photocurrents in 5/10 neurons. Meanwhile, Bic did not reduce 
photocurrents in all 4 neurons we recorded. All of the remaining currents were eliminated by 
MEC (Fig. 7G; Fig. S8C, D). These pharmacological properties are similar to the 
photocurrents in response to photo-excitation of PPN ChAT terminals in midbrain except 
that nAChRs on glutamatergic terminals had less contribution to these photocurrents (Fig. 
7G vs. Fig. 1K).
The above electrophysiological data indicate that the LDT and PPN ChAT neurons may have 
similar projections to the vSNc and VTA and therefore mediate similar behavioral outputs. 
We performed photo-excitation of LDT ChAT terminals in the vSNc and VTA to test 
whether the modulation leads to behavioral results similar to photo-excitation of PPN ChAT 
terminals. In open field tests, photo-excitation of neither LDT-to-VTA nor LDT-to-vSNc 
ChAT terminals altered locomotion (Fig. 7I, M), in contrast to the involvement of PPN-to-
vSNc projections in locomotion. In CPP assays, conditioning the rats with photo-excitation 
of LDT-to-VTA ChAT projections (Fig. 7H; Fig. S8A) increased the time spent in the light-
paired compartment (Fig. 7J, K), while shining blue light on LDT-to-vSNc projections (Fig. 
7L; Fig. S8B) to condition ChR2 and eYFP rats caused similar changes in their place 
preference (Fig. 7N, O). The results suggest that the PPN and LDT sends similar ChAT 
projections to the VTA regulating reward processing; in contrast to the PPN, LDT ChAT 
signaling to the vSNc did not alter locomotion.
To map the PPN and LDT ChAT projections to the VTA and vSNc, we injected retrograde 
herpes simplex viral (HSV) vectors carrying mCherry- and eYFP-Cre (Antinone and Smith, 
2010; Nieh et al., 2015), respectively, into the vSNc and VTA (Fig. 8A). The virus is taken 
up by terminals and transported along the axons to the somata, thereby labeling upstream 
neurons in the PPN and LDT. In both the PPN and LDT, VTA and vSNc projecting ChAT 
neurons and non-ChAT neurons were intermingled (Fig. 8B, C). The summarized data (Fig. 
8D) show that more ChAT neurons projected to the vSNc (PPN: 58%; LDT: 29%) than to 
the VTA (PPN: 20%; LDT: 25%), and 14% of ChAT neurons in both the PPN and LDT 
projected to both the vSNc and VTA. Compared with the LDT (Fig. 8D), the PPN had 
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significantly higher percentage of ChAT neurons projecting to either the vSNc, the VTA, or 
both (64% vs. 40%), higher percentage of vSNc projecting neurons (58% vs. 29%), but 
lower percentage of VTA projecting ChAT neurons (20% vs. 25%). The PPN and LDT had 
similar percentage of ChAT neurons projecting to both the VTA and vSNc (~ 14%) (Fig. 8 
D). Consistent with previous studies (Lammel et al., 2012; Mena-Segovia et al., 2008), 
ChAT neurons are not the only neuron population in the PPN and LDT projecting to the 
vSNc and VTA (Fig. 8B, C; Fig. S8E). Interestingly, a great majority of vSNc and a 
minority of VTA projecting neurons were cholinergic (Fig. S8E).
To clarify whether the projections from these two groups of ChAT neurons are intermingled 
in the vSNc and VTA, we delivered AAV5-DIO-eYFP in the PPN and AAV5-DIO-mCherry 
in the LDT to trace these projections (Fig. S8F). We observed that the ChAT fibers were 
adjacent to each other in both the vSNc and VTA (Fig. S8G). Interestingly, in the vSNc, 
PPN ChAT fibers significantly outnumbered LDT fibers, which is consistent with the 
retrograde tracing results and the differential roles observed in locomotion tests.
Discussion
The PPN contains heterogeneous cell populations with divergent brain-wide projections 
(Benarroch, 2013; Jenkinson et al., 2009; Mena-Segovia et al., 2008; Morita et al., 2014). It 
is implicated in a broad spectrum of behaviors, including locomotion, reward, and sleep 
(Arnulf et al., 2010; Benarroch, 2013; Maskos, 2008). The link between the PPN and these 
behaviors has mostly been obtained through neuromodulation with non-cell-specific 
pharmacological tools, electrical stimulation, and chemical lesions. Optogenetics (Gradinaru 
et al., 2009; Gradinaru et al., 2010; Hausser, 2014; Walsh et al., 2014) and chemogenetics 
(Sternson and Roth, 2014; Urban and Roth, 2015) provide tools that enable dissection of 
heterogeneous PPN circuits at the level of individual neuronal types. A few studies have 
taken advantage of these techniques to selectively enhance the activity of PPN ChAT 
neurons, from which it was observed that PPN ChAT neurons significantly modulate sleep 
(Van Dort et al., 2015) and motor functions (Pienaar et al., 2015; Roseberry et al., 2016). 
However, the behavioral effects of modulating PPN ChAT activity in opposing directions 
had yet to be explored.
We applied optogenetics to selectively target and bidirectionally modulate PPN ChAT 
neurons both at the somata and at the terminals, and further characterize the projections from 
these neurons to midbrain areas. First, we employed techniques that enable intact 
visualization of large tissue volume with high resolution (PACT (Treweek et al., 2015; Yang 
et al., 2014), Fig. 1B–C) and imaged the projections of PPN ChAT neurons to midbrain 
nuclei. Second, using retrograde HSV, we revealed that PPN ChAT neurons projecting to the 
VTA and vSNc are intermingled, and some neurons project to both the VTA and vSNc 
besides separate, parallel projections (Fig. 8B–D). Third, in acute brain slices, we applied 
optogenetics to stimulate endogenous ACh release which evoked non-synaptic responses in 
midbrain neurons through activating nAChRs in the recorded neurons and glutamate 
terminals (Fig. 1D–K; Fig. S1). Although some PPN ChAT neurons have been reported to 
contain glutamatergic and/or GABAergic marker proteins, it remains controversial whether 
these neurotransmitters are co-released from the terminals (Benarroch, 2013; Jenkinson et 
Xiao et al. Page 8
Neuron. Author manuscript; available in PMC 2017 April 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
al., 2009; Mena-Segovia et al., 2008; Roseberry et al., 2016; Wang and Morales, 2009). In 
our experiments, the extensive current attenuation by MEC (Fig. 1E–G, J; Fig. S1) suggests 
that ACh is the main underlying neurotransmitter and co-release of other neurotransmitters 
(e.g. glutamate or GABA) plays a minor, if any, role in PPN ChAT terminals in the 
midbrain, consistent with previous studies (Roseberry et al., 2016; Wang and Morales, 
2009).
PPN neurons are known to modulate motor behaviors. Electrical and chemical stimulation of 
the PPN enhance locomotion (Jenkinson et al., 2004), and nonspecific chemical lesion of the 
PPN leads to hypokinesia (Kojima et al., 1997; Masdeu et al., 1994). Moreover, direct in 
vivo electrophysiological recordings have shown that during voluntary movement (Jenkinson 
et al., 2009), imaginary motion, and passive movement (Tattersall et al., 2014), PPN neurons 
exhibit disparate changes (increased, decreased, or unchanged) in firing rates. These studies 
suggest that subsets of PPN neurons may be involved in motor control. We observed that 
photo-excitation of PPN ChAT neurons (20 Hz) caused hyperactivity (Fig. 4B) whereas 
photo-inhibition caused hypokinesia (Fig. 4C). Furthermore, the hyperactivity evoked by 
PPN ChAT-neuron stimulation was blocked by MEC (Fig. S4H,I), again suggesting either 
that these neurons do not co-release glutamate or that any co-released glutamate plays only a 
minor role in this behavior. These results demonstrate that bidirectional modulation of PPN 
ChAT neurons is sufficient to regulate locomotion and may be a potential therapeutic target 
for movement disorders involving both hypokinesia and involuntary movement.
In addition to locomotion, the PPN is also involved in reward processing: PPN neuronal 
activity changes in response to reward signals (Norton et al., 2011), and pharmacological 
inhibition or lesion of PPN neurons alters established addiction behavior, such as nicotine 
self-administration (Corrigall et al., 2002; Lanca et al., 2000). However, a causal link to a 
specific neuronal population in the PPN, whose modulation can affect reward behavior, has 
been lacking. Our results illustrate that optogenetic activation of PPN ChAT neurons lends 
positive emotional valence to previously aversive places (Fig. 4F–G). Conversely, inhibition 
of PPN ChAT neurons produces place aversion (Fig. 4H, I). Thus, PPN ChAT signaling can 
bidirectionally influence reinforcement learning.
A number of elegant studies have revealed complex roles for SNc and VTA neurons in 
exploratory activity, habituation, reinforcement, aversion, etc (Bromberg-Martin et al., 2010; 
Friedman et al., 2014; Lerner et al., 2015; Roeper, 2013; Walsh et al., 2014). We observed 
that stimulating ChAT terminals in the vSNc and VTA respectively modulate locomotion 
and reward (Fig. 5), suggesting that vSNc and VTA neurons receiving PPN ChAT 
innervation discriminately modulate locomotion and reward. Compared with the locomotor 
and reward phenotypes during modulation of PPN ChAT-neuron somata, terminal 
stimulation/inhibition tended to bring about smaller effects (Fig. 4B, C, G; Fig. 5C–F; Fig. 
6F), suggesting that ChAT connections to the vSNc and VTA may only partially mediate the 
roles of PPN ChAT neurons in motor control and reward processing.
Similar to the PPN ChAT neurons (Fig. 1H, K, Fig. S1), LDT ChAT neurons also innervate 
midbrain neurons (Fig. 7D–F) through activating nAChRs on both midbrain neurons and 
glutamatergic terminals (Fig. 7G; Fig. S8C–D). Optogenetic stimulation of VTA projecting 
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LDT glutamatergic neurons has previously been found to produce place preference (Lammel 
et al., 2012). Here, we observed that photoexcitation of LDT-to-VTA ChAT projections 
produced similar effects. These dual contributions of glutamatergic and ChAT neurons to 
conditioned reinforcement, as well as their physiological role in generating and maintaining 
burst firing in VTA neurons (Chen and Lodge, 2013; Lodge and Grace, 2006), bolster the 
role of the LDT in reward processing. By contrast, comparatively little is known about the 
LDT’s contribution to locomotion. Our anatomical data showed that LDT ChAT neurons 
also projected to the vSNc (Fig. 8C, D; Fig. S8G). However, the stimulation of these 
projections in vivo did not affect locomotion and reward processing (Fig. 7M–O). Thus, 
although the PPN and LDT are similar in neuronal composition, projection pathway, and 
their contributions to reward processing, they differ in their modulation of locomotion (Fig. 
8E). These differences and similarities align with their unique anatomical features. While the 
percentages of VTA-projecting ChAT neurons are comparable between the PPN and the 
LDT, noticeably more vSNc-projecting ChAT neurons reside in the PPN (Fig. 8D, E).
Brain-wide persistent augmentation of ChAT tone by genetically enhancing the sensitivity of 
nicotinic acetylcholine receptors (nAChRs), the actuators of ChAT transmission, produces a 
hyperactivity phenotype (Drenan et al., 2008) and facilitates nicotine reward-related 
behaviors (Tapper et al., 2004). In contrast, the knock-out of major subtype of nAChRs 
eliminates nicotine self-administration (Picciotto et al., 1998). These mouse genetic studies 
suggest that ChAT tone plays critical roles in both locomotion and reward reinforcement. 
Our results extend these studies by showing that temporally precise modulation of distinct 
ChAT pathways, originating in the mesopontine tegmentum, can exert contrasting actions on 
locomotion and reward (Fig. 8E). PPN ChAT neurons regulate locomotion and reward 
through divergent pathways connecting to the vSNc and VTA, respectively. A parallel LDT 
ChAT projection pathway modulates reward alone. Therefore, to refine the therapeutic 
treatment of movement disorders or drug addiction, it may be advantageous to specifically 
target discrete mesopontine cholinergic pathways (PPN-to-vSNc for enhancing motor 
function, and PPN/LDT-to-VTA for curbing addiction).
Experimental procedures
We used Long Evans wild type and Choline acetyl-transferase (ChAT)-Cre rats with Long 
Evans background (Witten et al., 2011). Animal husbandry and all experimental procedures 
involving rats were approved by the Institutional Animal Care and Use Committee (IACUC) 
and by the Office of Laboratory Animal Resources at the California Institute of Technology.
Surgeries for viral delivery, optical fiber implantation, and retrograde tracing
The rats were anesthetized with 2% isofluorane gas/carbogen mixture and stabilized on a 
stereotaxic frame (Kopf Instruments). AAV5-Ef1α-DIO-ChR2-eYFP, AAV5-Ef1α-DIO-
Arch3.0-eYFP, AAV5-Ef1α-DIO-eNpHR3.0-eYFP, AAV5-Ef1α-DIO-mCherry, or AAV5-
Ef1α-DIO-eYFP (0.8 μL, viral concentration is 4X1012 genome copies, UNC Vector Core) 
was injected in the PPN or LDT of ChAT-Cre rats (3 months old), and custom-made optical 
fiber guides (300 μm in diameter) were implanted above virus injection sites in the PPN, or 
above their projection nuclei (i.e. the vSNc and the VTA). Following surgery, rats were 
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single-housed on a 12 hrs light/dark cycle until behavioral testing (4–6 months old) or until 
electrophysiological recordings (4–7 months old).
For retrograde tracing, we injected herpes simplex virus carrying eYFP- and mCherry-Cre 
(MIT Viral Gene Transfer Core) in the VTA and the vSNc, respectively, and allowed the rats 
to recover for 3 weeks before imaging eYFP and mCherry in PPN ChAT and non-ChAT 
neurons.
Brain slice patch-clamp recordings
Electrophysiological recordings were performed on parasagittal brain slices, using the 
protocol described with some modifications (Xiao et al., 2015; Ye et al., 2006) (see 
supplementary materials).
In vivo single-unit recordings with optrodes
ChAT-Cre rats injected with AAV5-DIO-ChR2-eYFP into the PPN were anesthetized and 
optrodes, made as previously described (Gradinaru et al., 2007), were inserted into the VTA 
to track single-unit activity of VTA neurons before, during and after photoexcitation of 
ChR2-expressing PPN ChAT terminals in VTA.
Immunohistochemistry
We performed immunohistochemistry with conventional histology to identify ChR2-eYFP-/
Arch3.0-eYFP-positive neurons and processes, ChAT neurons, and DA neurons. To visualize 
optogenetically traced projections from PPN ChAT neurons to midbrain, we cleared 1–2 mm 
brain sections from ChR2-injected rats with PACT (Yang et al., 2014), performed 
immunohistochemistry to label ChR2-eYFP fibers and midbrain DA neurons (Fig. 1B, 5B), 
immersed the brain sections in refractive index matching solution (RIMS) in 1–2 mm deep 
square frames (iSpacer), and imaged the samples with a Zeiss LSM 780 confocal 
microscope.
Behavioral Assays
The rats with optical fiber implants were subject to open field and conditioned place 
preference (CPP) assays and their behaviors were acquired with a video camera controlled 
by Ethovision XT 9 software (Noldus et al., 2001).
Data analysis
Statistical analysis was performed by SigmaPlot 11.0 (SPSS Inc.) and OpenEpi (Dean et al., 
2010). Values of p < 0.05 were considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Optogenetic characterization of mesopontine cholinergic cells inputs to 
midbrain
• Separable pedunculopontine cholinergic pathways govern locomotion and 
reward
• Laterodorsal tegmental cholinergic inputs to VTA modulates reward
• Retrograde tracing reveals mesopontine cholinergic collateralization to VTA and 
SNc
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Fig. 1. PPN ChAT neurons form functional connections with distinct midbrain areas
(A) Stereotaxic microinjection of AAV5, carrying Ef1α-DIO-ChR2-eYFP, in the PPN of 
ChAT-Cre rats. (B) Representative Images from a 0.8 mm thick parasagittal midbrain section 
cleared with PACT and immune-stained for green fluorescent protein (ChR2-eYFP) and 
tyrosine hydroxylase (TH). (C) Expanded views of the vSNc and dSNc from (B). VTA 
image was from a more medial section. (D) Brain-slice recordings were performed on 
midbrain neurons. The neurons were selected by their location in the vSNc, dSNc, or VTA, 
and their proximity to ChR2-positive fibers (arrows). (E–G) Blue light stimulation induced 
inward currents in vSNc, dSNc, and VTA neurons (upper traces), and consequently 
enhanced firing (lower traces in E–G). Blue-light-evoked inward currents (E, F) and firing 
increases (E) were blocked by 10 μM MEC. (H) Percentages of neurons in the vSNc (33%, 
22/66), VTA (44%, 33/76), and dSNc (24.7%, 19/58) having responses to blue light. Black 
and gray stacks indicate the percentages of neurons responding or not responding to light 
stimulation, respectively. (I) Summary of light-evoked inward currents in vSNc (13.9±1.5 
pA), dSNc (11.8±1.5 pA), and VTA neurons (10.2±1.4 pA) (one-way ANOVA: F(2)=1.59, 
p=0.22). Numbers of recorded neurons are shown in the blank bars. (J) Summary of light 
enhancement of firing rates in vSNc (160±20% of baseline), dSNc (191±25% of baseline), 
and VTA neurons (169±14% of baseline) (one-way ANOVA: F(2) = 0.58, p = 0.58). (K) 
Summary of the effects of 1 μM atropine (128±19%), 10 μM Bic (86±5.5)%, 50 μM APV 
and 20 μM CNQX (APV+CNQX_1, partial blocking, 69±8.2%; APV+CNQX_2, complete 
blocking, 5±3%) on photo-currents. Compared with control: * p<0.05; ** p<0.01; 
Compared with Drug only: ##: p<0.01.
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Fig. 2. Biophysical properties of PPN ChAT neurons
(A) ChAT antibody staining in the PPN. (B) About 40% of PPN neurons are cholinergic 
(representative images; summary data t-test: p=0.86). (C) Typical neurobiotin labeled ChAT 
(upper panels) and non-ChAT (lower panels) neurons. (D) The activity of PPN neurons was 
modulated by current injections. (E) The averaged firing rate of PPN neurons in responses to 
2 s current injections. Data shown as means ± standard errors of the means. (F) Input 
resistance of PPN neurons (ChAT: 766±113 MΩ; non-ChAT: 308±52 MΩ, t-test: t=3.18, 
p=0.005). (G) The success rate of stimulus-evoked spikes (spike ratio) approached saturating 
levels when the injection currents were increased. (H) The spike delays after the initiation of 
current injections varied with stimulation frequency. (G) and (H) include data from 10 ChAT 
neurons and 8 non-ChAT neurons.
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Fig. 3. Optogenetic modulation of PPN ChAT neurons
(A) ChR2-eYFP-positive neurons (green) were ChAT-positive (red). (B) Percentages of 
ChAT neurons that were transduced with ChR2-eYFP (Caudal: 55±7%; Rostral: 53±10%; t-
test, t=0.17, p=0.87). The sections are from 3 rats (2–3 from each). (C) ChR2-eYFP was 
specifically transduced into ChAT neurons (Caudal: 96±2%; Rostral: 94±3%; t-test, t=0.93, 
p=0.37). (D) Blue light (3.1 mW/mm2) evoked inward currents in a ChR2-positive neuron 
(VH=−50 mV). (E) 20 Hz blue light stimuli evoked spikes in a ChR2-positive PPN neuron. 
(F) Scatter plots of spike delay for 20 trials of light-stimulation at 10, 20, and 50 Hz. (G) 
Success rate of light-evoked spikes. (H) Summary of the mean and variation (jitter) of spike 
delay. (I) AAV5-DIO-Arch3.0-eYFP was delivered to the PPN of ChAT-Cre rats. Arch-
eYFP-positive neurons were ChAT-positive. (J) Arch3.0-eYFP was transduced into ~60% of 
ChAT neurons. (K) >95% of Arch3.0-eYFP-positive neurons were ChAT neurons. (L) 
Green light (9 mW/mm2) induced an outward current (upper, VH=−50 mV), and silenced 
activity (lower) in Arch3.0-containing neurons (see also Fig. S3D).
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Fig. 4. PPN ChAT neurons regulate locomotion and reward
(A) AAV5 was used to transduce EF1α-DIO-ChR2-eYFP (ChR2), EF1α-DIO-Arch3.0-
eYFP (Arch3), or EF1α-DIO-mCherry (mCherry) into the PPN of ChAT-Cre rats. (B) Blue 
light reversibly increased voluntary movement in ChR2 rats, but not in mCherry rats (left, 
time course; right, summarized effects (ChR2: 173±13%; mCherry: 109±8%; Mann-
Whitney U test, p=0.001). (C) Green light reversibly reduced movement in Arch3 rats, but 
not in mCherry rats (left, time course; right, summarized effects (Arch3: 30±8%; mCherry: 
94±15%, Mann-Whitney U test, p=0.001)). (D) The conditioned place preference paradigm 
included a first-day baseline preference test, two 30 min conditioning sessions (light 
conditioning in the morning and no-light control in the afternoon) per day for four 
consecutive days, and a post-conditioning preference test. (E) During the light-conditioning 
sessions, ChR2 or mCherry rats were kept in the white compartment and received 20 Hz 
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blue light stimuli (left); Arch3/mCherry rats were kept in the dark compartment and 
conditioned with continuous green light (right). Blue and green lights were applied for 5 min 
epoch every 10 min. (F–G) Blue light conditioning increased the time that ChR2 rats, but 
not mCherry rats, spent in the white compartment (F, typical movement tracks before and 
after conditioning; G, summary of time changes (ChR2: 112±21 s; mCherry: 12±15 s, t-test, 
p=0.004)). (H–I) Green light conditioning reduced the time that Arch3 rats spent in the dark 
compartment (H, typical movement tracks before and after conditioning; I, summary of time 
changes (Arch3: −97±35 s; mCherry: 35±34 s, t-test, p=0.021). * p<0.05; ** p<0.01.
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Fig. 5. Optogenetic modulation of PPN ChAT terminals in the vSNc affects locomotion
(A) Optical fibers were implanted above the vSNc to activate (AAV5-DIO-ChR2-eYFP) or 
inhibit (AAV5-DIO-Arch3-eYFP) PPN–vSNc ChAT projections (parasagittal plane). (B) A 
parasagittal section (1 mm) from a ChR2 rat was cleared with PACT and stained with TH 
antibody. (C–D) Photo-excitation of PPN–vSNc ChAT terminals induced locomotor 
enhancement (C, time course; D, summary: (ChR2: 183±17%; mCherry: 95±15%, t-test, 
p=0.003)). (E–F) Photo-inhibition of PPN–vSNc ChAT terminals reduced locomotion (E, 
time course; F, summary: Arch3: 66±5%; mCherry: 100±11%; t-test: t=2.66, p=0.03). (G–
H) Photo-excitation of PPN-vSNc connections did not change CPP (G, typical exploration 
tracks in CPP chamber before and after photo-conditioning; H, summary of time changes in 
light-paired compartment (white compartment): ChR2: −22±26 s; mCherry: 9±23 s; t-test, 
p=0.40). * p<0.05; ** p<0.01.
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Fig. 6. Optogenetic modulation of PPN ChAT terminals in the VTA affects place preference
(A) ChR2-eYFP, eYFP, or eNpHR3.0-eYFP were virally transduced in PPN ChAT neurons 
of ChAT-Cre rats (coronal plane). (B) Optical fiber implants with a 10º angle relative to the 
dorsal-ventral axis were bilaterally placed above the VTA (coronal section). (C–D) Photo-
excitation of PPN–VTA ChAT projections did not change locomotion (C, time course; D, 
summary: ChR2: 103±4.3%; eYFP: 99±4.9%; t-test, p=0.67). (E–F) Photo-excitation of 
PPN–VTA ChAT projections increased time that the rats spent in light-paired compartment 
(E, typical exploration tracks in CPP chamber before and after photo-conditioning; F, 
summary: ChR2: 47±16 s; eYFP: −14±11 s; t-test, p=0.01). (G–H) Conditioning rats with 
photo-inhibition of PPN-VTA ChAT projections reduced their time spent in conditioned 
compartment (G, typical exploration tracks in CPP chamber before and after photo-
conditioning; H, summary: eNpHR3.0: −101±29 s; eYFP: 14.2±15.6 s; t-test, t=3.48, 
p=0.01). ** p<0.01.
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Fig. 7. Optogenetic stimulation of LDT-to-midbrain connections regulates CPP, but not 
locomotion
(A) AAV5-DIO-ChR2-eYFP or AAV5-DIO-eYFP was bilaterally injected in the LDT. (B) 
Typical images showing that ChR2-eYFP was selectively transduced in most LDT ChAT 
neurons. In 8 slices from 3 animals, 66% (368/556) of LDT ChAT neurons contained ChR2-
eYFP. (C) Blue light (3.1 mw/mm2) induced a robust inward current (5 s constant light) 
(VH=−50 mV) and reliably evoked spikes at 20 Hz (10 ms pulses). (D) Typical images 
showing a vSNc neuron (upper panel) adjacent to a ChR2 eYFP-positive fiber (lower panel). 
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(E) Blue light (5 s, 3.1 mw/mm2) evoked a MEC-sensitive inward current in a vSNc neuron 
(VH=−50 mV). (F) Blue light respectively induced inward currents in 24% (6/25), 18% 
(3/17), and 33% (13/39) of neurons in the vSNc, dSNc, and VTA. Chi Square test: χ2=1.66, 
p=0.44. (G) The photo-currents were partially blocked by APV+CNQX in some neurons, 
but not inhibited by either APV+CNQX or Bic in other neurons. These currents were 
completely abolished after addition of MEC. Drug vs. Control: ** p<0.01; Drug+MEC vs. 
Drug: ## p<0.01. (H) A typical image showing the position of implants in the VTA (in a 
parasagittal plane). (I) photo-excitation of LDT-to-VTA projections did not change 
locomotion. (J–K) Photo-excitation of LDT-to-VTA projections increased time spent in 
light-paired compartment (J, typical track tracing; K, summary of time changes in light-
paired (white) compartment after conditioning: ChR2: 75±26 s; eYFP: −57±20 s; t-test, 
t=3.7, p=0.004). (L) A typical image showing the position of implants in the vSNc (a 
parasagittal plane). (M) Photo-excitation of LDT-to-vSNc ChAT projections did not change 
locomotion. (N–O) Conditioning rats with photo-excitation of LDT-to-vSNc projections did 
not change the time spent in light-paired compartment (N, typical track tracing; O, summary 
of time changes in light-paired compartment after conditioning (ChR2: −87±5 s; eYFP: 
82±15 s; t-test, t=0.27, p=0.79).
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Figure 8. Retrograde tracing of PPN and LDT ChAT neurons from the VTA and vSNc
(A) The diagram shows that HSV-hEf1α-DIO-eYFP and HSV-hEf1α-DIO-mCherry are 
respectively injected in the VTA and vSNc. (B, C) Considerable proportions of ChAT and 
non-ChAT neurons in both the PPN (B) and LDT (C) were retrogradely labeled. Colored 
neurons (Green: VTA projecting neurons; Red: vSNc projecting neurons; Blue: ChAT 
staining); Colored arrows (green: VTA projection ChAT neuron; red: vSNc projecting ChAT 
neuron; yellow: ChAT neuron projecting to both the VTA and vSNc; open white arrow: non-
ChAT neurons). (D) Percentages of PPN and LDT ChAT neurons that projected to the VTA 
only (green stacks), the vSNc only (red stacks), both the VTA and vSNc (yellow stacks), and 
neither the VTA nor the vSNc (gray stacks). A total of 484 PPN ChAT neurons and 435 
LDT ChAT neurons were counted. (E) PPN and LDT ChAT neurons form connections with 
VTA neurons to a similar extent, and both modulate reward behavior; PPN ChAT neurons 
form stronger connections with vSNc neurons than LDT neurons do; excitation of PPN-
vSNc, instead of LDT-vSNc, ChAT terminals regulates locomotion. The PPN and LDT 
neurons are respectively marked with green and orange (solid: ChAT; open: non-ChAT).
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